Inflammatix
inflammatix.comLocations
Burlingame, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2016
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system. It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.
Something looks off?Open jobs at Inflammatix